Ritesh M. Pabari

686 total citations
19 papers, 429 citations indexed

About

Ritesh M. Pabari is a scholar working on Pharmaceutical Science, Molecular Biology and Oncology. According to data from OpenAlex, Ritesh M. Pabari has authored 19 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmaceutical Science, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Ritesh M. Pabari's work include Advanced Drug Delivery Systems (6 papers), Drug Solubulity and Delivery Systems (4 papers) and Protein purification and stability (4 papers). Ritesh M. Pabari is often cited by papers focused on Advanced Drug Delivery Systems (6 papers), Drug Solubulity and Delivery Systems (4 papers) and Protein purification and stability (4 papers). Ritesh M. Pabari collaborates with scholars based in Ireland, United Kingdom and Italy. Ritesh M. Pabari's co-authors include Zebunnissa Ramtoola, Gianluca Ciardelli, Clara Mattu, Monica Boffito, Trey Sunderland, Susanna Sartori, Brian P. Kirby, Piergiorgio Gentile, Catherine McCarthy and Chiara Tonda‐Turo and has published in prestigious journals such as International Journal of Molecular Sciences, International Journal of Pharmaceutics and European Journal of Pharmacology.

In The Last Decade

Ritesh M. Pabari

19 papers receiving 417 citations

Peers

Ritesh M. Pabari
Ion Mircioiu Romania
Lloyd Tillman United States
Isra Dmour Jordan
Jong Hyuck Park South Korea
Myoung Jin Ho South Korea
Roshan Pradhan South Korea
Ritesh M. Pabari
Citations per year, relative to Ritesh M. Pabari Ritesh M. Pabari (= 1×) peers Kahnu Charan Panigrahi

Countries citing papers authored by Ritesh M. Pabari

Since Specialization
Citations

This map shows the geographic impact of Ritesh M. Pabari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ritesh M. Pabari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ritesh M. Pabari more than expected).

Fields of papers citing papers by Ritesh M. Pabari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ritesh M. Pabari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ritesh M. Pabari. The network helps show where Ritesh M. Pabari may publish in the future.

Co-authorship network of co-authors of Ritesh M. Pabari

This figure shows the co-authorship network connecting the top 25 collaborators of Ritesh M. Pabari. A scholar is included among the top collaborators of Ritesh M. Pabari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ritesh M. Pabari. Ritesh M. Pabari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Pabari, Ritesh M., Murtaza M. Tambuwala, Natalia Lajczak, et al.. (2021). Novel polyurethane based particulate formulations of infliximab reduce inflammation in DSS induced murine model of colitis – A preliminary study. International Journal of Pharmaceutics. 604. 120717–120717. 8 indexed citations
2.
Chan, Yinghan, Ronan MacLoughlin, Flavia C. Zacconi, et al.. (2021). Advances in Nanotechnology-Based Drug Delivery in Targeting PI3K Signaling in Respiratory Diseases. Nanomedicine. 16(16). 1351–1355. 3 indexed citations
3.
Pabari, Ritesh M., et al.. (2019). Novel polyurethane-based nanoparticles of infliximab to reduce inflammation in an in-vitro intestinal epithelial barrier model. International Journal of Pharmaceutics. 565. 533–542. 26 indexed citations
4.
Pabari, Ritesh M., et al.. (2016). Effect of Thermal and Shear Stressors on the Physical Properties, Structural Integrity and Biological Activity of the Anti-TNF-alpha Monoclonal Antibody, Infliximab. Current Pharmaceutical Biotechnology. 17(10). 905–914. 13 indexed citations
5.
Boland, Karen, Lorna Flanagan, Niamh McCawley, et al.. (2016). Targeting the 19S proteasomal subunit, Rpt4, for the treatment of colon cancer. European Journal of Pharmacology. 780. 53–64. 10 indexed citations
6.
Pabari, Ritesh M., Denísio M. Togashi, Raquel Cama‐Moncunill, et al.. (2015). Multipoint near-infrared spectrometry for real-time monitoring of protein conformational stability in powdered infant formula. International Journal of Food Sciences and Nutrition. 66(5). 526–532. 3 indexed citations
7.
Gentile, Piergiorgio, Ritesh M. Pabari, Jacqueline S. Daly, et al.. (2015). Influence of Parathyroid Hormone-Loaded PLGA Nanoparticles in Porous Scaffolds for Bone Regeneration. International Journal of Molecular Sciences. 16(9). 20492–20510. 26 indexed citations
8.
Pabari, Ritesh M., et al.. (2014). Fast disintegrating crystalline solid dispersions of simvastatin for incorporation into orodispersible tablets. International Journal of Pharmaceutical Investigation. 4(2). 51–51. 8 indexed citations
9.
Pabari, Ritesh M., et al.. (2014). Influence of Prosolv and Prosolv:Mannitol 200 direct compression fillers on the physicomechanical properties of atorvastatin oral dispersible tablets. Pharmaceutical Development and Technology. 20(4). 394–400. 5 indexed citations
10.
Pabari, Ritesh M., et al.. (2014). Intranasal and intravenous administration of octa-arginine modified poly(lactic-co-glycolic acid) nanoparticles facilitates central nervous system delivery of loperamide. Journal of Pharmacy and Pharmacology. 67(4). 525–536. 23 indexed citations
11.
Mattu, Clara, Ritesh M. Pabari, Monica Boffito, et al.. (2013). Comparative evaluation of novel biodegradable nanoparticles for the drug targeting to breast cancer cells. European Journal of Pharmaceutics and Biopharmaceutics. 85(3). 463–472. 46 indexed citations
12.
Pabari, Ritesh M., et al.. (2013). Physical and Structural Stability of the Monoclonal Antibody, Trastuzumab (Herceptin®), Intravenous Solutions. Current Pharmaceutical Biotechnology. 14(2). 220–225. 22 indexed citations
13.
Kirby, Brian P., et al.. (2013). Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide. Journal of Pharmacy and Pharmacology. 65(10). 1473–1481. 19 indexed citations
14.
Pabari, Ritesh M., et al.. (2013). Physical and Structural Stability of the Monoclonal Antibody, Trastuzumab (Herceptin®), Intravenous Solutions. Current Pharmaceutical Biotechnology. 14(2). 220–225. 3 indexed citations
15.
Pabari, Ritesh M. & Zebunnissa Ramtoola. (2012). Application of face centred central composite design to optimise compression force and tablet diameter for the formulation of mechanically strong and fast disintegrating orodispersible tablets. International Journal of Pharmaceutics. 430(1-2). 18–25. 78 indexed citations
16.
Pabari, Ritesh M. & Zebunnissa Ramtoola. (2012). Effect of a Disintegration Mechanism on Wetting, Water Absorption, and Disintegration Time of Orodispersible Tablets. Journal of Young Pharmacists. 4(3). 157–163. 77 indexed citations
17.
Pabari, Ritesh M., Trey Sunderland, & Zebunnissa Ramtoola. (2012). Investigation of a novel 3-fluid nozzle spray drying technology for the engineering of multifunctional layered microparticles. Expert Opinion on Drug Delivery. 9(12). 1463–1474. 28 indexed citations
18.
Pabari, Ritesh M., et al.. (2012). Stability of an Alternative Extemporaneous Captopril Fast-Dispersing Tablet Formulation Versus an Extemporaneous Oral Liquid Formulation. Clinical Therapeutics. 34(11). 2221–2229. 16 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026